Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 5/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28474885 | 0.89 | CHRNB4 (0.52) | NISCHCHRNB4CHRNA3ALDH1A1GAA | |
| SCHEMBL6810811 | 0.82 | ALDH1A1 (0.44) | NISCHCHRNB4CHRNA3ALDH1A1GAA | |
| SCHEMBL2274850 | 0.74 | NISCH (0.35) | NISCHCHRNB4CHRNA3ALDH1A1GAA | |
| SCHEMBL4151921 | 0.72 | MAPK10 (0.41) | RAB9ANPC1PTGS2NOTUMMAPK10 | |
| SCHEMBL14525912 | 0.70 | ALDH1A1 (0.46) | ALDH1A1GAARAB9ANPC1MAPK1 | |
| SCHEMBL9197869 | 0.70 | NISCH (0.40) | NISCHCHRNB4CHRNA3ALDH1A1GAA | |
| SCHEMBL895819 | 0.69 | CHRNB4 (0.67) | NISCHCHRNB4CHRNA3ALDH1A1GAA | |
| SCHEMBL12997586 | 0.67 | ALDH1A1 (0.47) | ALDH1A1RAB9ANPC1MAPK1ADORA3 | |
| SCHEMBL1068403 | 0.67 | — | — | |
| SCHEMBL576916 | 0.67 | ALDH1A1 (0.47) | ALDH1A1RAB9ANPC1MAPK1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109384733-B | Method for preparing celecoxib intermediate compound in high yield under mild condition | 新发药业有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-109384733-A | The method of Sai Lexipa midbody compound is prepared under a kind of temperate condition in high yield | 新发药业有限公司 | 2019-02-26 | — | — | CN | disclosed |
| US-8084145-B2 | Organometallic complex, light emitting element using the complex, light emitting device using the element, and electric apparatus using the device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8084145-B2 | Organometallic complex, light emitting element using the complex, light emitting device using the element, and electric apparatus using the device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8084145-B2 | Organometallic complex, light emitting element using the complex, light emitting device using the element, and electric apparatus using the device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-7993494-B2 | Method for manufacturing triarylpyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7993494-B2 | Method for manufacturing triarylpyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| CN-101481357-B | Preparation of quinoxaline derivatives | UNIV TIANJIN NORMAL | 2010-12-08 | — | — | CN | disclosed |
| US-20090183982-A1 | Method for Manufacturing Triarylpyrazine Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-07-23 | — | — | US | disclosed |
| US-20090183982-A1 | Method for Manufacturing Triarylpyrazine Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-07-23 | — | — | US | disclosed |
| CN-101481357-A | Preparation of quinoxaline derivatives | UNIV TIANJIN NORMAL (CN) | 2009-07-15 | — | — | CN | disclosed |
| US-7355075-B2 | Reacting a compound of a hydroxyl functionality, a carbonyl functionality, or both a hydroxyl functionality and a carbonyl functionality with reactant having an amine functionality in the presence of ordered porous manganese-based octahedral molecular sieves and an oxygen gas | THE UNIVERSITY OF CONNECTICUT (US) | 2008-04-08 | — | — | US | disclosed |
| US-7355075-B2 | Reacting a compound of a hydroxyl functionality, a carbonyl functionality, or both a hydroxyl functionality and a carbonyl functionality with reactant having an amine functionality in the presence of ordered porous manganese-based octahedral molecular sieves and an oxygen gas | THE UNIVERSITY OF CONNECTICUT (US) | 2008-04-08 | — | — | US | disclosed |
| US-20070027344-A1 | METHOD OF PRODUCING IMINES | THE UNIVERSITY OF CONNECTICUT (US) | 2007-02-01 | — | — | US | disclosed |
| US-20070027344-A1 | METHOD OF PRODUCING IMINES | THE UNIVERSITY OF CONNECTICUT (US) | 2007-02-01 | — | — | US | disclosed |
| US-20050221123-A1 | Organometallic complex, light emitting element using the complex, light emitting device using the element, and electric apparatus using the device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2005-10-06 | — | — | US | disclosed |
| EP-0397859-A1 | PYRAZINE DERIVATIVES AND MEDICINAL PREPARATION CONTAINING SAME | TERUMO KABUSHIKI KAISHA (JP) | 1990-11-22 | — | — | EP | disclosed |
| EP-0194686-B1 | PYRAZINE DERIVATIVES | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1989-12-20 | — | — | EP | disclosed |
| US-4788197-A | ANTICOAGULANTS | TERUMO KABUSHIKI KAISHA (JP) | 1988-11-29 | — | — | US | disclosed |
| EP-0194686-A1 | Pyrazine derivatives | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1986-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027344-A1 | METHOD OF PRODUCING IMINES | MT-CO2, INMT, SCO2 | NISCH 175/4885CHRNB4 3860/4885CHRNA3 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.